ZA991325B - Novel group B streptococcus antigens. - Google Patents

Novel group B streptococcus antigens.

Info

Publication number
ZA991325B
ZA991325B ZA9901325A ZA991325A ZA991325B ZA 991325 B ZA991325 B ZA 991325B ZA 9901325 A ZA9901325 A ZA 9901325A ZA 991325 A ZA991325 A ZA 991325A ZA 991325 B ZA991325 B ZA 991325B
Authority
ZA
South Africa
Prior art keywords
novel group
streptococcus antigens
streptococcus
antigens
novel
Prior art date
Application number
ZA9901325A
Other languages
English (en)
Inventor
Clement Rioux
Denis Martin
Bernard R Brodeur
Josee Hamel
Isabelle Charlebois
Martine Boyer
Original Assignee
Biochem Vaccines Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biochem Vaccines Inc filed Critical Biochem Vaccines Inc
Publication of ZA991325B publication Critical patent/ZA991325B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
    • C07K14/315—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Streptococcus (G), e.g. Enterococci
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K39/00—Medicinal preparations containing antigens or antibodies

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Communicable Diseases (AREA)
  • Oncology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
ZA9901325A 1998-02-20 1999-02-18 Novel group B streptococcus antigens. ZA991325B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US7542598P 1998-02-20 1998-02-20

Publications (1)

Publication Number Publication Date
ZA991325B true ZA991325B (en) 1999-08-20

Family

ID=22125658

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA9901325A ZA991325B (en) 1998-02-20 1999-02-18 Novel group B streptococcus antigens.

Country Status (22)

Country Link
US (4) US20030031682A1 (zh)
EP (3) EP1757697A3 (zh)
JP (2) JP4637350B2 (zh)
KR (1) KR100771148B1 (zh)
CN (2) CN1268745C (zh)
AP (1) AP2000001886A0 (zh)
AT (1) ATE347600T1 (zh)
AU (1) AU2505999A (zh)
CA (1) CA2321106C (zh)
CZ (1) CZ301056B6 (zh)
DE (1) DE69934299T2 (zh)
EA (1) EA200000860A1 (zh)
ES (2) ES2540281T3 (zh)
HU (1) HU228497B1 (zh)
ID (1) ID27482A (zh)
IL (3) IL137921A0 (zh)
NO (2) NO330491B1 (zh)
NZ (1) NZ529854A (zh)
OA (1) OA11686A (zh)
TR (1) TR200002437T2 (zh)
WO (1) WO1999042588A2 (zh)
ZA (1) ZA991325B (zh)

Families Citing this family (30)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR100771148B1 (ko) 1998-02-20 2007-10-29 아이디 바이오메디칼 코포레이션 그룹 ｂ 스트렙토코커스 항원
CA2337102A1 (en) * 1998-07-27 2000-02-10 Richard William Falla Le Page Nucleic acids and proteins from group b streptococcus
US7098182B2 (en) 1998-07-27 2006-08-29 Microbial Technics Limited Nucleic acids and proteins from group B streptococcus
US6890539B2 (en) 1998-12-22 2005-05-10 Microscience, Ltd. Genes and proteins, and their use
GB0105922D0 (en) * 2001-03-09 2001-04-25 Microscience Ltd Genes and proteins, and their use
WO2000037646A2 (en) 1998-12-22 2000-06-29 Microscience Limited Group b streptococcus proteins, and their use
US7128918B1 (en) 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
WO2001014421A1 (en) * 1999-08-25 2001-03-01 Medimmune, Inc. Homologs of a pneumococcal protein and fragments for vaccines
US6833356B1 (en) 1999-08-25 2004-12-21 Medimmune, Inc. Pneumococcal protein homologs and fragments for vaccines
ES2273861T3 (es) * 2000-06-12 2007-05-16 University Of Saskatchewan Inmunizacion de ganado vacuno lechero con proteina gapc frente a infecciones por streptococcus.
US6833134B2 (en) 2000-06-12 2004-12-21 University Of Saskacthewan Immunization of dairy cattle with GapC protein against Streptococcus infection
EP1734050A3 (en) * 2000-06-12 2012-12-05 University Of Saskatchewan Immunization of dairy cattle with GapC protein against streptococcus infection
US6866855B2 (en) 2000-06-12 2005-03-15 University Of Saskatchewan Immunization of dairy cattle with GapC protein against Streptococcus infection
DK1294771T3 (da) 2000-06-12 2008-12-15 Univ Saskatchewan Kimært GapC-protein fra Streptococcus og anvendelse deraf til vaccinering og diagnosticering
JP4102186B2 (ja) * 2000-10-13 2008-06-18 アイディー バイオメディカル コーポレイション グループｂストレプトコッカスのｂｖｈ−ａ２及びｂｖｈ−ａ３抗原
EP2189473A3 (en) 2000-10-27 2010-08-11 Novartis Vaccines and Diagnostics S.r.l. Nucleic and proteins from streptococcus groups A & B
AU2002216863B8 (en) * 2000-12-21 2008-03-20 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
FR2824074A1 (fr) * 2001-04-26 2002-10-31 Pasteur Institut Sequence du genome streptococcus agalactiae, application au developpement de vaccins, d'outils de diagnostic, et a l'identification de cibles therapeutiques
ATE543906T1 (de) * 2002-02-11 2012-02-15 Id Biomedical Corp Antigen von streptococcus aus der b-gruppe
GB0210128D0 (en) * 2002-05-02 2002-06-12 Chiron Spa Nucleic acids and proteins from streptococcus groups A & B
US7709009B2 (en) 2003-07-31 2010-05-04 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for streptococcus pyogenes
US8945589B2 (en) 2003-09-15 2015-02-03 Novartis Vaccines And Diagnostics, Srl Immunogenic compositions for Streptococcus agalactiae
JP2008508320A (ja) 2004-07-29 2008-03-21 カイロン コーポレイション Ｓｔｒｅｐｔｏｃｏｃｃｕｓａｇａｌａｃｔｉａｅのようなグラム陽性細菌に対する免疫原性組成物
WO2006042027A2 (en) 2004-10-08 2006-04-20 Novartis Vaccines And Diagnostics Inc. Immunogenic and therapeutic compositions for streptococcus pyogenes
WO2006086330A2 (en) * 2005-02-08 2006-08-17 Id Biomedical Corporation Of Quebec C.O.B. As Glaxosmithkline Biologicals North America Pharmaceutical compositions
GB0605247D0 (en) * 2006-03-15 2006-04-26 Chiron Srl Compositions and methods for immunisation
JP5653215B2 (ja) 2007-09-12 2015-01-14 ノバルティス アーゲー Ｇａｓ５７変異体抗原およびｇａｓ５７抗体
KR20160114196A (ko) 2007-12-21 2016-10-04 노파르티스 아게 스트렙토라이신 ｏ의 돌연변이 형태
CN102304185A (zh) * 2011-09-02 2012-01-04 黑龙江八一农垦大学 预防奶牛乳房炎的融合蛋白sip-trap及制备方法和应用
EP2949340A1 (en) * 2014-05-30 2015-12-02 IDT Biologika GmbH Vaccine composition against Streptococcus suis infection

Family Cites Families (19)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4425437A (en) 1979-11-05 1984-01-10 Genentech, Inc. Microbial polypeptide expression vehicle
US4431739A (en) 1979-11-05 1984-02-14 Genentech, Inc. Transformant bacterial culture capable of expressing heterologous protein
US5302386A (en) 1986-04-16 1994-04-12 Brigham And Women's Hospital, Inc. Bacterial antigens, antibodies, vaccines and methods of manufacture
US5472696A (en) 1988-02-26 1995-12-05 Univ. Of Florida Research Foundation, Inc. Antigen of group B streptococci
US5648241A (en) 1989-09-15 1997-07-15 The General Hospital Corporation Conjugate vaccine against group B streptococcus
US5679768A (en) 1991-02-15 1997-10-21 Uab Research Foundation Epitopic regions of pneumococcal surface protein A
US5225331A (en) 1991-04-25 1993-07-06 National Research Council Of Canada Immunoassay for detecting group b streptococcus
SI0656014T1 (en) 1993-03-19 2003-12-31 Gunnar Lindahl Protein rib, a cell surface protein that confers immunity to many strains of the group b streptococcus; process for purification of the protein, reagent kit and pharmaceutical composition
US5595740A (en) 1994-05-16 1997-01-21 University Of Florida Cloning of non-IgA FC binding forms of the group B streptococcal beta antigens
CA2180261C (en) * 1994-11-01 2003-03-18 Aruto Yoshida Peptide sequence that forms mucin sugar chain and technique for modifying protein to be linked with mucin sugar chain
DE69739981D1 (de) * 1996-10-31 2010-10-14 Human Genome Sciences Inc Streptococcus pneumoniae-Antigene und Impfstoffe
KR100771148B1 (ko) * 1998-02-20 2007-10-29 아이디 바이오메디칼 코포레이션 그룹 ｂ 스트렙토코커스 항원
US6248329B1 (en) * 1998-06-01 2001-06-19 Ramaswamy Chandrashekar Parasitic helminth cuticlin nucleic acid molecules and uses thereof
CA2337102A1 (en) 1998-07-27 2000-02-10 Richard William Falla Le Page Nucleic acids and proteins from group b streptococcus
US6582706B1 (en) 1998-12-21 2003-06-24 Medimmune, Inc. Vaccine compositions comprising Streptococcus pneumoniae polypeptides having selected structural MOTIFS
CA2356836C (en) 1998-12-23 2011-09-13 Shire Biochem Inc. Novel streptococcus antigens
US7128918B1 (en) * 1998-12-23 2006-10-31 Id Biomedical Corporation Streptococcus antigens
GB9921125D0 (en) 1999-09-07 1999-11-10 Microbial Technics Limited Proteins
ATE543906T1 (de) 2002-02-11 2012-02-15 Id Biomedical Corp Antigen von streptococcus aus der b-gruppe

Also Published As

Publication number Publication date
CN1944652A (zh) 2007-04-11
NO20101682L (no) 2000-10-19
EP2280072A2 (en) 2011-02-02
EP1757697A3 (en) 2007-05-30
NZ529854A (en) 2005-08-26
HUP0102304A3 (en) 2008-03-28
WO1999042588A3 (en) 2000-03-23
JP4637350B2 (ja) 2011-02-23
IL137921A0 (en) 2001-10-31
AP2000001886A0 (en) 2000-09-30
US20030228323A1 (en) 2003-12-11
EA200000860A1 (ru) 2001-10-22
EP2280072A3 (en) 2012-06-06
EP1757697A2 (en) 2007-02-28
TR200002437T2 (tr) 2000-11-21
AU2505999A (en) 1999-09-06
DE69934299T2 (de) 2007-07-05
ID27482A (id) 2001-04-12
IL137921A (en) 2008-06-05
HU228497B1 (en) 2013-03-28
ATE347600T1 (de) 2006-12-15
NO330491B1 (no) 2011-05-02
IL190018A0 (en) 2008-08-07
DE69934299D1 (de) 2007-01-18
US8226953B2 (en) 2012-07-24
WO1999042588A2 (en) 1999-08-26
KR20010034518A (ko) 2001-04-25
CN1297482A (zh) 2001-05-30
NO20004161L (no) 2000-10-19
CA2321106A1 (en) 1999-08-26
JP2009242403A (ja) 2009-10-22
CA2321106C (en) 2013-07-23
US7914794B2 (en) 2011-03-29
JP2002507396A (ja) 2002-03-12
US8580262B2 (en) 2013-11-12
CZ20003054A3 (cs) 2001-03-14
US20030031682A1 (en) 2003-02-13
ES2278436T3 (es) 2007-08-01
OA11686A (en) 2005-01-12
ES2540281T3 (es) 2015-07-09
EP1054971B1 (en) 2006-12-06
HUP0102304A1 (hu) 2001-10-28
NO20004161D0 (no) 2000-08-18
EP1054971A2 (en) 2000-11-29
US20130095498A1 (en) 2013-04-18
IL190018A (en) 2011-07-31
US20110182923A1 (en) 2011-07-28
CZ301056B6 (cs) 2009-10-29
KR100771148B1 (ko) 2007-10-29
CN1268745C (zh) 2006-08-09
EP2280072B1 (en) 2015-03-25

Similar Documents

Publication Publication Date Title
ZA991325B (en) Novel group B streptococcus antigens.
IL194230A0 (en) Novel streptococcus antigens
AU7038101A (en) Streptococcus antigens
EP0680049A3 (en) Synchronization arrangement.
PL331585A1 (en) 2- 2,5-substituted phenylketoneoles
ZA996185B (en) Sulfanylsilanes.
ZA200005136B (en) Dihydropyrimides.
ZA9710429B (en) Broad-spectrumδ-endotoxins.
ZA200101637B (en) Cyclone.
ZA9811939B (en) Novel macrolides.
ZA991272B (en) Novel thiobenzamides.
DE69723848D1 (en) 3-descladinose-2,3-anhydroerythromycin-derivate
ZA978799B (en) Mycosis vaccine.
ZA992443B (en) Hydroxy-methyl-hexanones.
ZA978379B (en) Synchronizer.
ZA993123B (en) Trisresorcinyltriazines.
ZA995325B (en) Methylcyclotetradec-5-en-1-ones.
ZA97928B (en) Novel heteroaryl-oxazolidinones.
ZA987029B (en) Synchronizer.
GB9928678D0 (en) Streptococcus pneumoniae antigens
GB9825184D0 (en) Antigen
IL138958A0 (en) Streptococcus preparation
AU2003200963A1 (en) Group B Streptococcus Antigens
GB9800760D0 (en) Antigens
ZA989435B (en) Novel aryloxy-alkyl-dialkylamines.